Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DCVax-Direct in advanced solid tumors
NCT01882946Phase 2Unknown
- Sponsor
- Northwest Biotherapeutics
- Start
- Jun 2013
- Primary completion
- Dec 2016
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of dcvax-direct in solid tumor, sponsored by Northwest Biotherapeutics. Status: unknown.
02
Drugs
dcvax-direct
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT01882946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01882946.